David E. Allie, MD
Director of Cardiothoracic and Endovascular Surgery
Director of Peripheral Vascular Studies
Cardiovascular Institute of the South/Lafayette
Lafayette, LA
Nicolas W. Shammas, MD, MS
Research Director, Midwest Cardiovascular Research Foundation
Clinical Assistant Professor, University of Iowa
Interventional Cardiologist, Cardiovascular Medicine, PC
Davenport, IA
This activity has been developed for Physicians, Pharmacists, Nurses, and Technologists with an interest in the diagnosis and treatment of peripheral artery disease.
There is no fee for this educational activity.
Upon completion of this educational activity, participants should be able to:
- Discuss the role of platelet inhibition in PVD
- Discuss treatment strategies for patients with CLI
- Provide appropriate medical management of patients with vascular disease.
MD/DO:
This activity is sponsored by the North American Center for Continuing Medical Education (NACCME) NACCME is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
NACCME designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit(s) . Each physician should claim only those credits that he/she actually spent in the educational activity. Physicians should only claim credit commensurate with the extent of their participation in the activity.
This activity has been planned and produced in accordance with the ACCME Essential Areas and Policies.
Pharmacists:
The North American Center for Continuing Medical Education (NACCME) is accredited by the American Council for Pharmacy Education as a provider of continuing pharmaceutical education.
NACCME designates this continuing education activity for 1 contact hours (0.10 CEU’s) of the American Council for Pharmacy Education. Universal Program Number 276-000-06-016-L01.
A statement of credit will be issued only upon receipt of a completed activity self-test.
Nurses:
North American Center for Continuing Medical Education is an approved provider of continuing nursing education by the Pennsylvania State Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. This continuing nursing education activity was approved by the PA State Nurses Association for 1 contact hour(s). Provider #: 110-3-E-03.
Provider approved by the California Board of Registered Nursing, Provider Number 13255 for 1 contact hour.
Technologists:
Radiologic: Activities approved by the American Medical Association (AMA Category 1) are eligible for ARRT Category B credit as long as they are relevant to the radiologic sciences. Radiologic Technologists, registered by the ARRT, may claim up to 12 Category B credits per biennium.
All faculty participating in Continuing Education programs sponsored by the North American Center for Continuing Medical Education are expected to disclose to the meeting audience any real or apparent conflict(s) of interest related to the content of their presentation. It is not assumed that these financial interests or affiliations will have an adverse impact on faculty presentations.
Doctor Allie has disclosed that he is a consultant for Toshiba and Bracco.
Doctor Shammas has disclosed that he has received grant/research support from The Medicines Company, Boston Scientific and Possis. He is a member of the Speakers’ Bureau for The Medicines Company, Sanofi-Aventis, BMS, GSK and Edwards.
This activity is supported by an educational grant from Schering-Plough Corporation.

Sponsored by the North American Center for Continuing Medical Education (NACCME).